Publications

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China.

Weerasuriya, CK; Harris, RC; MCQUAID, CF; BOZZANI, F; Ruan, Y; Li, R; Li, T; Rade, K; Rao, R; Ginsberg, AM; Gomez, GB; WHITE, RG;

2022

BMC medicine, (2022).20 1 10.1186/s12916-022-02306-3.

Public perceptions and interactions with UK COVID-19 Test, Trace and Isolate policies, and implications for pandemic infectious disease modelling.

Marshall, GC; Skeva, R; Jay, C; Silva, ME P; Fyles, M; House, T; Davis, EL; Pi, L; MEDLEY, GF; QUILTY, BJ; Dyson, L; Yardley, L; FEARON, E;

2022

F1000Research, (2022).11, 10.12688/f1000research.124627.1.

Heavy-tailed sexual contact networks and the epidemiology of monkeypox outbreak in non-endemic regions, May 2022.

Endo, A; Murayama, H; ABBOTT, S; RATNAYAKE, R; PEARSON, C; EDMUNDS, J; FEARON, E; FUNK, S;

2022

medRxiv (2022). 10.1101/2022.06.13.22276353.

Modelling the synergistic effect of bacteriophage and antibiotics on bacteria: killers and drivers of resistance evolution.

LECLERC, Q; Lindsay, J; Knight, G;

2022

bioRxiv (2022). 10.1101/2022.03.02.480504.

Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.

Echeverria-Londono, S; Hartner, A-M; Li, X; Roth, J; Portnoy, A; SBARRA, AN; ABBAS, K; Ferrari, M; FU, H; JIT, M; Ferguson, NM; Gaythorpe, KA M;

2022

Vaccine, (2022).40 47 10.1016/j.vaccine.2022.09.049.

Stakeholders' Engagement in Interactive Agent-Based Model Building to Explore Health System Performance.

Mziray, N; Maiba, J; Binyaruka, P; CASSIDY, R; BORGHI, J; FOSS, A;

2022

. Abstract accepted for poster presentation (2022).

The United States COVID-19 Forecast Hub dataset.

Cramer, EY; Huang, Y; Wang, Y; Ray, EL; Cornell, M; Bracher, J; Brennen, A; Rivadeneira, AJ C; Gerding, A; House, K; Jayawardena, D; Kanji, AH; Khandelwal, A; Le, K; Mody, V; Mody, V; Niemi, J; Stark, A; Shah, A; Wattanchit, N; Zorn, MW; Reich, NG; US COVID-19 Forecast Hub Consortium,;

2022

Scientific data, (2022).9 1 10.1038/s41597-022-01517-w.

In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis.

Bolotin, S; Osman, S; Hughes, SL; Ariyarajah, A; Tricco, AC; Khan, S; Li, L; Johnson, C; Friedman, L; Gul, N; Jardine, R; Faulkner, M; Hahné, SJ M; Heffernan, JM; Dabbagh, A; Rota, PA; Severini, A; JIT, M; Durrheim, DN; Orenstein, WA; Moss, WJ; FUNK, S; Turner, N; Schluter, W; Jawad, JS; ... Crowcroft, NS.

2022

The Journal of infectious diseases, (2022).226 7 10.1093/infdis/jiac039.

Estimation of the test to test distribution as a proxy for generation interval distribution for the Omicron variant in England.

ABBOTT, S; SHERRATT, K; Gerstung, M; FUNK, S;

2022

(2022). 10.1101/2022.01.08.22268920.

Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test case.

Kochhar, S; Barreira, D; Beattie, P; Cavaleri, M; Cravioto, A; Frick, MW; Ginsberg, AM; Hudson, I; Kaslow, DC; Kurtz, S; Lienhardt, C; Madhi, SA; Morgan, C; Momeni, Y; Patel, D; Rees, H; Rogalski-Salter, T; Schmidt, A; Semete-Makokotlela, B; Voss, G; WHITE, RG; Zignol, M; Giersing, B;

2022

Vaccine, (2022).40 12 10.1016/j.vaccine.2021.10.062.